Mechano growth factor (MGF) is associated with an IGF-1 splice-variant research context and is studied in cell-signaling and tissue-response models. The original overview of this page asks three questions: MGF terminology and the IGF-1 splice-variant context, cell and tissue signaling models, and sequence identity, purity, and sample stability.
Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.
MGF terminology and the IGF-1 splice-variant context
Yang and Goldspink described a splice variant of insulin-like growth factor-I (IGF-I) that they called mechano growth factor (MGF), and they distinguished the IGF-I Ec peptide (MGF) from mature IGF-I (Yang and Goldspink, 2002). In that terminology, MGF is not the same material as mature IGF-I, and it is not IGF-1 LR3 (Long R3 IGF-I). A related identity note on Long R3 IGF-I is at What Is IGF-1 LR3?.
Catalog or secondary articles sometimes use “PEG-MGF” or other modified names. Those are additional identifiers if they appear. A splice-variant name is not a complete specification until the sequence, any modification, and the lot report agree.
Cell-signaling observations
In an in-vitro myoblast model, Yang and Goldspink reported that, unlike mature IGF-I, the distinct E domain of MGF inhibited terminal differentiation while increasing myoblast proliferation. Blocking the IGF-I receptor with a specific antibody indicated, in their design, that the function of the MGF E domain was mediated via a different receptor (Yang and Goldspink, 2002). Those are cell-culture observations. They are not a tissue-level or clinical outcome, and they are not a use instruction.
Sequence identity, purity, and stability
Because splice-variant and mature IGF-I peptides can be confused in a file, the brief should name the form actually purchased. Purity and stability records belong with that form. What Is a Peptide COA?, How to Read a Peptide COA, HPLC vs Mass Spectrometry for Peptide Lot Review, Third-Party Peptide Testing, Explained, and lot traceability apply independently to this row.
MGF was not found as a standalone published item in Velnacor’s current research-material catalog listing used for this draft (IGF-1 LR3 is a different catalog row). Use the product directory and the COA Library, then confirm whether a current SKU exists and which lot documents apply in the inquiry. For packing at supply scale, see wholesale peptides.
Secondary listings sometimes add PEGylation or other modifications under a related trade or catalog name. Those forms are additional materials if they are actually purchased. They should not inherit a splice-variant file, and a PEG-MGF name should not be invented as a current Velnacor SKU. Sample age, storage condition as recorded on receipt, and the sequence actually listed on the certificate belong in the same folder as the identity check. This page does not prescribe a stability protocol.
Because MGF terminology grew out of IGF-I splice-variant research, a laboratory file should also record whether the experiment is asking a question about the E domain, about mature IGF-I, or about a long analogue such as IGF-1 LR3. Those are different analytes even when they share a superfamily heading.
Selected published literature
- Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Letters. 2002;522(1-3):156-160. doi:10.1016/s0014-5793(02)02918-6. PubMed 12095637.
Sourcing notes for qualified buyers
Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.
Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.
Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.